Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging

被引:24
作者
Bhutani, Manisha [1 ,2 ]
Turkbey, Baris [3 ]
Tan, Esther [1 ]
Korde, Neha [1 ,4 ]
Kwok, Mary [1 ]
Manasanch, Elisabet E. [1 ,5 ]
Tageja, Nishant [1 ]
Mailankody, Sham [1 ]
Roschewski, Mark [1 ]
Mulquin, Marcia [1 ]
Carpenter, Ashley [1 ]
Lamping, Elizabeth [1 ]
Minter, Alex R. [1 ]
Weiss, Brendan M. [1 ,6 ]
Mena, Esther [3 ]
Lindenberg, Liza [3 ]
Calvo, Katherine R. [7 ]
Maric, Irina [7 ]
Usmani, Saad Z. [2 ]
Choyke, Peter L. [3 ]
Kurdziel, Karen [3 ]
Landgren, Ola [1 ,4 ]
机构
[1] NCI, Multiple Myeloma Sect, Lymphoid Malignancies Branch, CCR,NIH, Bethesda, MD 20892 USA
[2] Carolinas HealthCare Syst, Levine Canc Inst, Charlotte, NC USA
[3] NCI, Mol Imaging Program, CCR, NIH, Bethesda, MD 20892 USA
[4] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[7] NIH, Hematol Sect, DLM, CC, Bldg 10, Bethesda, MD 20892 USA
关键词
MGUS; smoldering myeloma; multiple myeloma; functional imaging; DCE-MRI; NaF; FDG; PET; CT; UNDETERMINED SIGNIFICANCE MGUS; MONOCLONAL GAMMOPATHY; PROGNOSTIC-SIGNIFICANCE; FLOW-CYTOMETRY; FDG PET/CT; LONG-TERM; RISK; PROGRESSION; MANAGEMENT; F-18-FDG;
D O I
10.3109/10428194.2015.1090572
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The incidence and importance of bone marrow involvement and/or early bone lesions in multiple myeloma (MM) precursor diseases is largely unknown. This study prospectively compared the sensitivity of several imaging modalities in monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM) and MM. Thirty patients (10 each with MGUS, SMM and MM) were evaluated with skeletal survey, [F-18]FDG-PET/CT, [F-18]NaF-PET/CT and morphologic dynamic contrast enhanced (DCE)-MRI. An additional 16 SMM patients had skeletal surveys and FDG-PET/CT. Among MGUS patients, DCE-MRI found only one focal marrow abnormality; other evaluations were negative. Among 26 SMM patients, five (19%) were re-classified as MM based on lytic bone lesions on CT and six had unifocal or diffuse marrow abnormality. Among MM, marrow abnormalities were observed on FDG-PET/CT in 8/10 patients and on DCE-MRI in nine evaluable patients. Abnormal NaF uptake was observed only in MM patients with lytic lesions on CT, providing no additional clinical information.
引用
收藏
页码:1114 / 1121
页数:8
相关论文
共 21 条
[1]
Bhutani M, 2014, RADIOLOGE, V54, P572, DOI 10.1007/s00117-014-2694-7
[2]
Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial [J].
Bhutani, M. ;
Turkbey, B. ;
Tan, E. ;
Kemp, T. J. ;
Pinto, L. A. ;
Berg, A. R. ;
Korde, N. ;
Minter, A. R. ;
Weiss, B. M. ;
Mena, E. ;
Lindenberg, L. ;
Aras, O. ;
Purdue, M. P. ;
Hofmann, J. N. ;
Steinberg, S. M. ;
Calvo, K. R. ;
Choyke, P. L. ;
Maric, I. ;
Kurdziel, K. ;
Landgren, O. .
LEUKEMIA, 2014, 28 (02) :413-416
[3]
Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement [J].
Dimopoulos, Meletios A. ;
Hillengass, Jens ;
Usmani, Saad ;
Zamagni, Elena ;
Lentzsch, Suzanne ;
Davies, Faith E. ;
Raje, Noopur ;
Sezer, Orhan ;
Zweegman, Sonja ;
Shah, Jatin ;
Badros, Ashraf ;
Shimizu, Kazuyuki ;
Moreau, Philippe ;
Chim, Chor-Sang ;
Lahuerta, Juan Jose ;
Hou, Jian ;
Jurczyszyn, Artur ;
Goldschmidt, Hartmut ;
Sonneveld, Pieter ;
Palumbo, Antonio ;
Ludwig, Heinz ;
Cavo, Michele ;
Barlogie, Bart ;
Anderson, Kenneth ;
Roodman, G. David ;
Rajkumar, S. Vincent ;
Durie, Brian G. M. ;
Terpos, Evangelos .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (06) :657-U186
[4]
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma [J].
Dispenzieri, Angela ;
Kyle, Robert A. ;
Katzmann, Jerry A. ;
Therneau, Terry M. ;
Larson, Dirk ;
Benson, Joanne ;
Clark, Raynell J. ;
Melton, L. Joseph, III ;
Gertz, Morie A. ;
Kumar, Shaji K. ;
Fonseca, Rafael ;
Jelinek, Diane F. ;
Rajkumar, S. Vincent .
BLOOD, 2008, 111 (02) :785-789
[5]
Durie BGM, 2002, J NUCL MED, V43, P1457
[6]
Current Concepts in the Evaluation of Multiple Myeloma with MR Imaging and FDG PET/CT [J].
Hanrahan, Christopher J. ;
Christensen, Carl R. ;
Crim, Julia R. .
RADIOGRAPHICS, 2010, 30 (01) :127-U153
[7]
Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significance [J].
Hillengass, J. ;
Weber, M-A ;
Kilk, K. ;
Listl, K. ;
Wagner-Gund, B. ;
Hillengass, M. ;
Hielscher, T. ;
Farid, A. ;
Neben, K. ;
Delorme, S. ;
Landgren, O. ;
Goldschmidt, H. .
LEUKEMIA, 2014, 28 (01) :174-178
[8]
Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma [J].
Hillengass, Jens ;
Fechtner, Kerstin ;
Weber, Marc-Andre ;
Baeuerle, Tobias ;
Ayyaz, Sofia ;
Heiss, Christiane ;
Hielscher, Thomas ;
Moehler, Thomas M. ;
Egerer, Gerlinde ;
Neben, Kai ;
Ho, Anthony D. ;
Kauczor, Hans-Ulrich ;
Delorme, Stefan ;
Goldschmidt, Hartmut .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (09) :1606-1610
[9]
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management [J].
Kyle, R. A. ;
Durie, B. G. M. ;
Rajkumar, S. V. ;
Landgren, O. ;
Blade, J. ;
Merlini, G. ;
Kroeger, N. ;
Einsele, H. ;
Vesole, D. H. ;
Dimopoulos, M. ;
San Miguel, J. ;
Avet-Loiseau, H. ;
Hajek, R. ;
Chen, W. M. ;
Anderson, K. C. ;
Ludwig, H. ;
Sonneveld, P. ;
Pavlovsky, S. ;
Palumbo, A. ;
Richardson, P. G. ;
Barlogie, B. ;
Greipp, P. ;
Vescio, R. ;
Turesson, I. ;
Westin, J. ;
Boccadoro, M. .
LEUKEMIA, 2010, 24 (06) :1121-1127
[10]
A long-term study of prognosis in monoclonal gammopathy of undetermined significance [J].
Kyle, RA ;
Therneau, TM ;
Rajkumar, SV ;
Offord, JR ;
Larson, DR ;
Plevak, MF ;
Melton, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (08) :564-569